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Abstract
Background: Malaria in pregnancy in India, as elsewhere, is responsible for maternal anemia and adverse
pregnancy outcomes such as low birth weight and preterm birth.
It is not known whether prevention and treatment strategies for malaria in pregnancy (case management, insecti-
cide-treated bednets, intermittent preventive therapy) are widely utilized in India.
Methods: This cross-sectional study was conducted during 2006-2008 in two states of India, Jharkhand and
Chhattisgarh, at 7 facilities representing a range of rural and urban populations and areas of more versus less stable
malaria transmission. 280 antenatal visits (40/site) were observed by study personnel coupled with exit interviews of
pregnant women to assess emphasis upon, availability and utilization of malaria prevention practices by health workers
and pregnant women. The facilities were assessed for the availability of antimalarials, lab supplies and bednets.
Results: All participating facilities were equipped to perform malaria blood smears; none used rapid diagnostic
tests. Chloroquine, endorsed for chemoprophylaxis during pregnancy by the government at the time of the study,
was stocked regularly at all facilities although the quantity stocked varied. Availability of alternative antimalarials for
use in pregnancy was less consistent. In Jharkhand, no health worker recommended bednet use during the
antenatal visit yet over 90% of pregnant women had bednets in their household. In Chhattisgarh, bednets were
available at all facilities but only 14.4% of health workers recommended their use. 40% of the pregnant women
interviewed had bednets in their household. Only 1.4% of all households owned an insecticide-treated bednet; yet
40% of all women reported their households had been sprayed with insecticide. Antimalarial chemoprophylaxis
with chloroquine was prescribed in only 2 (0.7%) and intermittent preventive therapy prescribed in only one (0.4%)
of the 280 observed visits.
Conclusions: A disconnect remains between routine antenatal practices in India and known strategies to prevent
and treat malaria in pregnancy. Prevention strategies, in particular the use of insecticide-treated bednets, are
underutilized. Gaps highlighted by this study combined with recent estimates of the prevalence of malaria during
pregnancy in these areas should be used to revise governmental policy and target increased educational efforts
among health care workers and pregnant women.
Background
Infection with malaria during pregnancy carries signifi-
cant risks to both mother and baby. An estimated
50 million pregnancies worldwide occur in areas where
malaria is a concern [1]. In areas of low or unstable
malaria transmission, pregnant women have little
acquired immunity to malariaa n da r ea ti n c r e a s e dr i s k
of symptomatic malaria, severe malaria, anemia and
adverse birth outcomes such as miscarriage, preterm
labor or stillbirth [2,3]. In areas of stable transmission,
symptomatic maternal infections occur less frequently,
yet the mother remains at risk for severe anemia and
the fetus at risk for low birth weight and consequently * Correspondence: bwylie@partners.org
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preterm birth [1,2,4,5].
Ninety-five percent of India’sp o p u l a t i o ni sa tr i s kf o r
malaria with an estimated 2 to 3 million cases reported
annually nationwide [6,7]. Malaria transmission in India
is predominantly unstable with pockets of more stable
transmission [6]. Although less studied than exposed
pregnancies in sub-Saharan Africa, epidemiological stu-
dies of malaria in pregnancy in India have demonstrated
similar adverse pregnancy outcomes such as anemia,
preterm labor, stillbirth and low birth weight [8-12].
Strategies for prevention and control of malaria during
pregnancy include prompt recognition and treatment of
women with symptomatic illness (case management) and
a package of prevention measures encompassing use of
insecticide-treated bednets (ITNs) and provision of inter-
mittent preventive therapy in pregnancy (IPTp) [13]. In
India, the government has initiated measures to improve
malaria prevention and treatment, with a special emphasis
on pregnant women and children. Several states have ben-
efitted from the Enhanced Malaria Control Project funded
by the World Bank from 1997 to 2005, which emphasized
an integrated approach to malaria control including early
case detection and prompt treatment, vector control with
targeted indoor residual spraying, distribution of ITNs,
increased public awareness through informational
campaigns and strengthening of regional institutions to
provide malaria surveillance and control of outbreaks
[14,15]. In addition, the official policy endorsed by the
National Vector Borne Disease Control Program through
2007 recommended chloroquine chemoprophylaxis during
pregnancy for women living in high-risk areas [16].
It is not known whether this comprehensive preg-
nancy malaria control strategy that exists on paper has
been widely adopted in India. We conducted this study
to assess the knowledge, availability and utilization of
malaria prevention and treatment strategies among
pregnant women and health care workers (HCWs) in
two malaria-endemic states of eastern India in order to
inform policy recommendations.
Methods
Study Sites
This study was one component of two larger cross-
sectional surveys conducted in the states of Jharkhand
and Chhattisgarh that assessed the burden of malaria in
pregnancy using rapid field assessment methodology
developed by the United States Centers for Disease Con-
trol and Prevention [17]. Jharkhand and Chhattisgarh
were chosen because they contribute 7% and 13%,
respectively, of all annually reported malaria cases in
India [6]. Seven antenatal clinics (ANCs), three in Jhark-
hand and four in Chhattisgarh, were purposively
selected in order to include a range of rural and urban
populations and areas of more versus less stable malaria
transmission.
In Jharkhand (Figure 1), we chose three facilities to
ensure inclusion of rural, semi-urban and urban popula-
tions. The Ursula Mission Hospital serves a predomi-
nantly rural population and is situated in Konbir
(Gumla district). Approximately 1200 ANC visits are
performed at this hospital each year. Konbir is situated
very close to the border of Simdega, a highly malarious
d i s t r i c tw i t has l i d ep o s i t i v er a t e( S P R )o f1 4 %i n2 0 0 5
[18]. Civil Hospital, the district hospital for Gumla
district, serves a semi-urban population and performs
2000 ANC visits annually. The SPR for Gumla district
was 3.4% in 2005 with substantially higher rates
reported in the recent past, ranging from 10% to 19.7%
between 1997 and 2003 [18]. Sadar Hospital, the district
hospital in Ranchi, is located in an urban location aver-
aging between 3200 and 3600 annual ANC visits. The
SPR for Ranchi district was 7.2% in 2005 [18].
The study protocol for Chhattisgarh was designed
after initiation of research activities in Jharkhand with a
slightly different aim of enrolling women in areas of
more stable versus less stable malaria transmission
rather than based on urbanity alone. In Chhattisgarh
(Figure 1), two districts were targeted. Bastar district has
stable, seasonal transmission of malaria while Rajnand-
gaon district is characterized by unstable transmission.
The SPR in Bastar district was 12.1% in 2005 [19]. In
Rajnandgaon, the SPR was 1.6% in 2005. Within each
district, we selected both a rural and an urban ANC.
Rural antenatal facilities chosen were the Keskal Com-
munity Health Center (Bastar district) and Dongargarh
Community Health Center (Rajnandgaon district) with
approximately 750 and 1500 ANC visits per year,
respectively. The urban ANCs were located at Konda-
gaon Ravindra Nath Taigore Community Health Center
(Bastar district) and at District Hospital Rajnandgaon
(Rajnandgaon district) and reported an average of 1500
and 2450 ANC visits per year, respectively.
Data from our contemporaneous cross-sectional sur-
veys of unselected pregnant women presenting for ANC
care during a twelve month period at these same study
sites revealed a prevalence of peripheral parasitemia of
1.8% in Jharkhand [20] and 1.2% in Chhattisgarh (2.8%
in Bastar district and 0% in Rajnandgaon district) [21].
T h ep r e v a l e n c eo fp l a c e n t a lparasitemia among women
presenting for delivery at these study sites during the
same time period was 2.4% in Jharkhand and 3.1% in
Chhattisgarh (3.6% in Bastar district and 3.2% in
Rajnandgaon district) [20,22].
Paired ANC observations and exit interviews
Pregnant women presenting for antenatal care at the
participating ANC facilities were approached for study
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ticipating antenatal clinics and gave a brief overview of
the study to pregnant women waiting to be seen for
antenatal care. Women interested in participation were
enrolled if they were ≥15 years of age, had not pre-
viously participated in the study and were willing to
provide informed consent. Trained study personnel
observed the antenatal visit conducted by the HCW,
noting, with the aid of a checklist, what history was
taken, parts of the physical exam were performed,
laboratory tests were ordered and health information
was communicated. The study nurse accompanied the
research subject to the laboratory and the pharmacy to
verify the laboratory tests ordered and the medications
prescribed. Following the ANC visit, the study nurse
conducted an exit interview with the subject. Informa-
tion collected included socio-demographics, malaria pre-
vention measures used during pregnancy and
satisfaction with the health information received during
the antenatal visit. Specific malaria prevention measures
discussed included ownership of a bednet, treatment of
the bednet with an insecticide, personal use of the bed-
n e to nt h ep r i o rn i g h ta n do nm o s tn i g h t s ,u s eo fa n t i -
malarial chemoprophylaxis, and household insecticide
spraying by the government at any time point. Upon
completion of a paired HCW observation and client exit
interview, recruitment of additional subjects from those
waiting to be seen for antenatal care was carried out
until the targeted number of 40 per site was achieved.
HCWs at each of the participating ANC sites were
oriented to the study objectives and procedures prior to
study initiation and agreed to have their antenatal visits
observed. Observed ANC visits included both initial
prenatal appointments as well as return visits.
Facility assessments
Study personnel conducted a structured facility assess-
ment survey at each of the seven participating ANCs.
Along with background information about the facilities,
study personnel focused on four key areas: antenatal
Figure 1 Map of Jharkhand and Chhattisgarh states with study sites identified. Arrows indicate the health facilities where data collection
took place: Jharkhand state (Ranchi- urban; Gumla- semiurban; Konbir- rural) and Chhattisgarh state (Bastar district, stable transmission: Keskal-
rural and Kondagaon- urban; Rajnandgaon district, unstable transmission: Rajnandgaon- urban and Dongargarh- rural).
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nely collected, malaria diagnostic capabilities and avail-
ability of bednets and antimalarial drugs. Interviewers
consulted physicians, block medical officers, dispensary
attendants and laboratory technicians to complete these
assessments. In addition to detailed questions, an inven-
tory of stocked supplies and drugs was performed.
Inventory records were reviewed to identify relevant
malaria supply stockouts in the previous six months.
Ethical clearance
This study was approved by the Institutional Review
Boards of Boston University and the Centers for Disease
Control and Prevention, the Ethics Committee of the
National Institute of Malaria Research in India, the
Scientific Advisory Committee of the National Institute
of Malaria Research and the Health Ministry Screening
Committee of the Indian Council of Medical Research.
Data management and analysis
For the paired ANC observations-exit interviews, case
report forms and study procedures were evaluated in a
pilot study and modified accordingly. All case report
forms were checked for completeness and inappropriate
or illogical responses. The forms were double-entered
using CS-Pro Version 4.0 (United States Census Bureau,
Washington, DC), with range, consistency and edit
checks built into the data entry program for quality con-
trol. The two databases were validated and all inconsis-
tencies and differences were resolved. Statistical analyses
were performed using SAS software version 9.1 (Cary,
North Carolina). Categorical data are presented as fre-
quency counts (percent) and compared using the chi-
square or Fisher’s exact statistic as appropriate. Since
most participants did not know their exact date of birth,
we categorized subjects’ ages in ranges based on their
estimations.
Results
Paired ANC observations and exit interviews
Recruitment and enrollment took place during Decem-
ber 2006 through January 2007 in Jharkhand and
December 2007 to March 2008 in Chhattisgarh. In
Jharkhand, 120 pregnant women were enrolled, while
160 pregnant women were enrolled in Chhattisgarh
(40 per ANC site). The proportion of ANC visits
observed during the study period ranged from 5% to
20%, varying from site to site depending on the volume
of total ANC visits at each site. Table 1 provides the
socio-demographic characteristics of subjects enrolled in
the ANC observations-exit interviews. Of all subjects,
nearly all were married (99.6%) and most (77.5%) were
engaged in household work. Hindi was the predominant
language spoken at home (99.2%). Nearly one-fifth of
subjects had never received formal schooling. The vast
majority were members of traditionally disadvantaged
populations now given administrative recognition:
“Scheduled Tribes” (26.1%), originally indigenous people
who are now fairly integrated with mainstream society;
“Other Backward Castes” (33.9%), encompassing diverse
groups not included in other classifications; and, “Sched-
uled Castes” (23.6%), primarily consisting of historically
lower castes. 16.4% were “General Caste”, comprised of
all other individuals, including formerly higher castes.
Table 2 details key observations made during the
antenatal visits by research staff. Greater than 99% of the
ANC visits were conducted by a physician. In general, an
evaluation for anemia by history, physical examination
and/or lab testing was more common than assessments
for other signs or symptoms of malaria (history of fever,
measurement of temperature, ordering blood smear).
Hemoglobin levels were measured at nearly three-fourths
of all visits (72.8%) whereas blood smears were obtained
for about one-quarter of subjects (27.5%). Both hemoglo-
bin and blood smears were ordered significantly more
often by HCWs in Chhattisgarh than in Jharkhand. In
Jharkhand, malaria was rarely discussed and bednets
were never recommended. There was more of a focus on
malaria in Chhattisgarh with one quarter of HCWs
reviewing malaria protection measures with a specific
mention of bednets in 15.6% of the discussions. In Chhat-
tisgarh, HCWs were more likely to recommend a bednet
in Bastar district, with stable malaria transmission com-
pared with Rajnandgaon district, with unstable transmis-
sion (24% vs. 5%, p = 0.002). Antimalarial prophylaxis
Table 1 Enrolled Pregnant Women Demographics
Jharkhand
n = 120
Chhattisgarh
n = 160
Age (years)
15-19 9.2% 7.5%
20-34 85.0% 90.0%
> 35 5.8% 2.5%
Married 100% 99.4%
Hindi primary language spoken 100% 98.8%
Caste
General Caste 12.5% 19.4%
Schedule Caste 26.7% 21.3%
Other Backward Caste 30.8% 36.3%
Schedule Tribe 30.0% 23.1%
No formal schooling* 20.8% 14.4%
Primary occupation
Housework 78.3% 76.9%
Farming 7.5% 12.5%
Other 14.2% 10.6%
* p = 0.002 comparing Jharkhand with Chhattisgarh participants. No other
significant differences between study sites with regard to participant
demographics.
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prophylaxis was prescribed in only 2 (0.7%) and intermit-
tent preventive therapy prescribed in only one (0.4%) of
the 280 overall observed visits.
The most widely utilized malaria prevention measure
was sleeping under a bednet (Table 3). Over 90% of sub-
jects in Jharkhand had a bednet in their household and
the vast majority (82.5%) had slept under it the prior
night. Household bednet availability was much lower in
Chhattisgarh (40% of households) and only one-half of
subjects with an available bednet had slept under it the
prior night. In both states, most bednets were untreated,
not ITNs. In contrast, 40% of all women reported that
their households had been sprayed with insecticide by
the government at some point. As anticipated from the
observed ANC visits, use of antimalarial chemoprophy-
laxis during the pregnancy was extremely rare in both
states with only one participant, who was unaware of
the exact medicine prescribed, reporting use of
chemoprophylaxis.
Facility Assessments
Health center assessments surveys were conducted by
study personnel at each of the 7 participating ANC facil-
ities during the month of December 2006 in Jharkhand
and November 2007 in Chhattisgarh. All facilities had
the onsite capability to perform and diagnose malaria by
blood smear, with the exception of the district hospital
in Rajnandgaon, whose microscope was not functional
a tt h et i m eo fe v a l u a t i o n( T a b l e4 ) .R a p i dd i a g n o s t i c
tests were not available at any of the surveyed facilities.
Chloroquine was available at all facilities and was the
most widely and well stocked antimalarial. The stock of
chloroquine ranged in quantity from 500 tablets in
Gumla (Jharkhand) to 15,000 tablets in Dongargarh
(Chhattisgarh). Only 1 of the 7 facilities had experienced
a chloroquine stockout, defined as a one month period
of time without drug, in the six months preceding the
assessment. Sulfadoxine-pyrimethamine, widely used in
sub-Saharan Africa for IPTp, was available at only 3 of
the 7 facilities and was absent from the largest ANC in
each state (Ranchi and Rajnandgaon). Artesunate,
utilized for the treatment of uncomplicated malaria in
nonpregnant adults, usually as part of combination ther-
apy with a second drug and increasingly used in preg-
nant women beyond the first trimester, was available at
only 1 site. Among injectable antimalarials, arte-ether
was available more commonly than quinine. Iron and
folic acid supplements were provided to all women at
each health center but one facility had none in stock at
the time of the evaluation (Gumla).
There was considerable variability in the availability
and distribution of bednets at the participating ANCs.
In Jharkhand, bednets were only available in Gumla. An
average of 2200 ITNs was distributed by the office of
the district malaria officer that was housed in the same
medical complex as the ANC at Civil Hospital in
Gumla. Notably, bednets were not distributed specifi-
cally to pregnant women at the time of an antenatal
v i s i ta n d ,a sd o c u m e n t e di nt h eH C Wo b s e r v a t i o n s ,
none of the HCWs recommended bednet use or specifi-
cally referred women to the adjacent malaria office for
procurement of a bednet. In contrast, all facilities in
Chhattisgarh had bednets available for distribution to
pregnant women, with average monthly distribution ran-
ging from 5 to 200. All of the nets distributed in Don-
gargarh and Keskal were insecticide-treated, only some
were insecticide-treated in Rajnandgaon, and none were
treated in Kondagaon. Retreatment kits were available at
only 2 of the 7 facilities. Where available, bednets were
distributed free of charge.
Discussion
Malaria prevention and treatment during pregnancy is
only one component of antenatal care and must
Table 2 Health Care Worker Observations
Jharkhand
n = 120
Chhattisgarh
n = 160
Asks about presence of fever* 20.0% 48.1%
Measures temperature 17.5% 15.6%
Obtains blood smear* 14.2% 37.5%
Assesses for signs/symptoms of anemia* 40.8% 75.0%
Checks hemoglobin* 54.2% 86.9%
Discusses malaria protection measures* 0.8% 25.0%
Prescribes antimalarial prophylaxis 0.8% 1.3%
Recommends bednet use* 0% 15.6%
Level of HCW training
Doctor 99.2% 100%
Nurse 0.8% 0%
HCW = health care worker.
* p < 0.001 comparing Jharkhand with Chhattisgarh participants.
Table 3 Utilization of malaria prevention measures by
pregnant women
Jharkhand
n = 120
Chhattisgarh
n = 160
Reports malaria as a large concern in
pregnancy*
76.7% 36.3%
Bednet available in household* 90.8% 40%
Slept under bednet last night* 82.5% 20%
Insecticide-treated bednet in household
† 3.3% 0%
Use of chemoprophylaxis in pregnancy 0% 0.6%
Government ever sprayed house with
insecticide
¶
50.8% 31.9%
* p < 0.001 comparing Jharkhand with Chhattisgarh participants.
† p = 0.02 comparing Jharkhand with Chhattisgarh participants.
¶ p = 0.001 comparing Jharkhand with Chhattisgarh participants.
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providers such as providing nutritional advice, screening
for hypertensive complications of pregnancy, treating
anemia and identifying obstetric complications. None-
theless, this study highlights sporadic gaps in malaria
diagnostic and treatment capabilities and an overall
underutilization of malaria prevention strategies at the
7 participating antenatal clinics in eastern India.
Case Management
In areas of both stable and unstable malaria transmis-
sion, timely diagnosis of malaria episodes is crucial to
preventing the adverse sequelae of such infections dur-
ing pregnancy. At the time that the surveys were con-
ducted, the Directorate of Health Services in both
states–Jharkhand and Chhattisgarh–recommended
early diagnosis and treatment with effective antimalar-
ials for pregnant women attending ANCs [18,19],
guidelines that were consistent with those advised by
the National Vector Borne Disease Control Program
[16]. All participating facilities had onsite capability to
perform malaria blood smears and, with the exception
o fo n es i t ew h o s em i c r o s c o p ew a sb r o k e n ,t h ee q u i p -
ment was functional and the relevant supplies well
stocked. Rapid diagnostic tests were not used in any of
the study ANCs. These might be a useful addition to
the repertoire of diagnostic tools, particularly in
facilities that lack the onsite capability to perform or
interpret malaria blood smears [23].
Blood smears were not routinely ordered but more
typically obtained in situations where fever or other
malarial symptoms were divulged. Yet, queries about the
presence of fever were made in only a minority of the
ANC visits (36%), thus highlighting a potential way to
improve case recognition. Asking each pregnant client
about current or past fevers since the last visit and
reflexively ordering blood smears for those who respond
affirmatively would add minimal additional time to a
r o u t i n ev i s i ta n dm a yb eam o r er e a l i s t i cs t r a t e g yi n
areas of unstable malaria transmission when compared
with routine collection of blood smears. Although our
s t u d yd i dn o ta s c e r t a i nt h ep roportion of moderate to
severe anemic women who were subsequently screened
for malaria, such targeted blood smears would be an
additional relevant consideration for improving case
recognition among women with underlying partial
immunity who might not mount a febrile response to
the parasite. Such targeted blood smears, in the pre-
sence of a fever or moderate to severe anemia, should
be considered by the government in future antenatal
policy recommendations.
In addition to malaria diagnostic capacity, case man-
agement requires ready access to effective antimalarial
drug regimens suitable for a pregnant population.
Table 4 Facility Assessments
Jharkhand Chhattisgarh
Gumla
(Semi-urban)
Konbir
(Rural)
Ranchi
(Urban)
Rajnandgaon
(Urban)
Dongargarh
(Rural)
Kondagaon
(Urban)
Keskal
(Rural)
Bednets available for PW √√ √ √ √
Insecticide-treated bednets √ some √√
Average # bednets distrubuted/month 2200* 200 30 20 5
Antimalarials in stock
Chloroquine √√ √ √ √ √ √
Quinine (injectable) √√ √
SP √√
Artesunate √
Arteether (injectable) √√ √ √ √ √ √
Micronutrients in stock
Multivitamin √√ √ √ √
Iron/folic acid √√ √ √ √ √ √
Stockouts in past 6 months
Chloroquine
Quinine v √√ √ √
SP √√ √ √ √
Functional thermometer √√ √ √ v √
Functional microscope √√ √ √ √ √
Onsite malaria smear √√ √ √ √ √
√= present. PW = pregnant woman; SP = sulfadoxine-pyrimethamine.
*Distributed at adjacent office of the district malaria officer but not specifically targeted to pregnant women.
Wylie et al. BMC Public Health 2010, 10:557
http://www.biomedcentral.com/1471-2458/10/557
Page 6 of 9Chloroquine, with its longstanding safety profile in preg-
nancy [24], was widely available at all of the antenatal
facilities in relatively ample supply with only a single
stockout at one facility. Nonetheless, chloroquine resis-
tance has been reported in India, as elsewhere, particu-
larly in areas of intense P. falciparum transmission such
as the northeastern states [6,12]. Artemisinin combina-
tion therapy was introduced for nonpregnant individuals
as early as 2006 by the government in areas showing
chloroquine resistance [25]. Alternatives to chloroquine
for malaria treatment during pregnancy are urgently
needed yet we found that other antimalarials, including
quinine, sulfadoxine-pyrimethamine and artemisinin
derivatives, were much less widely available. Oral artesu-
nate was available at only one site. By contrast, arte-
ether for parenteral treatment of severe malaria was
available at all seven study sites. Furthermore, little gui-
dance is provided to HCWs caring for pregnant women
regarding appropriate antimalarial treatment in the
National Drug Policy on Malaria 2007 guidelines avail-
able at the time our study was conducted [16]. Certain
antimalarials are prohibited from use during pregnancy–
primaquine and parenteral artemesin derivatives. Yet,
recommendations for which regimens to use for treat-
ment of complicated or uncomplicated malaria during
pregnancy are notably absent. To improve appropriate
treatment of women with malaria in pregnancy, govern-
ment agencies should outline treatment guidelines speci-
fic to pregnancy and target educational efforts to
antenatal providers.
Malaria Prevention Measures
A keystone of the Enhanced Malaria Control Program,
active in both Jharkhand and Chattisgarh just prior to
the initiation of our study, was the enhanced provision
of ITNs and their regular retreatment. In addition to a
policy of increasing ITN use, both state governments
also had existing vector control strategies that primarily
consisted of indoor residual spraying with either dichlor-
odiphenyltrichloroethane (DDT) or synthetic pyrethroids
[18,19]. It was encouraging to note that a culture of
bednet use by pregnant women existed in Jharkhand
despite the fact that distribution occurred at none of the
facilities during routine antenatal visits. We acknowl-
edge that bednet use was self-reported and not verified
by research staff. It is possible that women may have
over-reported their use of bednets since they were
aware of the study’s focus upon malaria.
Availability of bednets at ANCs was higher in Chhat-
tisgarh, but the majority of pregnant women did not
regularly sleep under the nets. Except in Bastar district,
there was an almost universal lack of insecticide treat-
ment of the nets in both Jharkhand and Chhattisgarh.
Approaches to bednet distribution, particularly ITNs,
and improved community awareness of the importance
of their use need to be addressed. Long-lasting ITNs
m a yb ep r e f e r a b l eg i v e nt h ea d d i t i o n a lc h a l l e n g e so f
retreatment. The ANC visit is an ideal setting for distri-
bution of ITNs and education in the importance of their
u s ed u r i n gp r e g n a n c ys i n c et he majority of pregnancy
women attend at least one antenatal visit, 85% in Jhark-
hand [26] and 80% in Chhattisgarh [27].
Weekly chloroquine prophylaxis has generally fallen
out of favor worldwide given several drawbacks:
increased parasite resistance to the drug with conse-
quent decreased efficacy and poor adherence to the pro-
longed regimen [28-30]. Chloroquine prophylaxis was
rarely utilized for prevention of malaria in pregnancy at
our study sites despite being recommended officially at
the time the study was conducted [16]. This recommen-
dation subsequently was dropped in the most recent
Indian national drug policy guidelines on malaria, which
were published in 2008 [31].
An alternative to weekly chemoprophylaxis widely
adopted in Africa is IPTp, a strategy which delivers at
least two curative doses of antimalarial treatment
beyond the first trimester. Sulfadoxine-pyrimethamine is
the most commonly administered drug for IPTp. The
advantages of IPTp over weekly chemoprophylaxis
include improved adherence and ease of delivery. Sulfa-
doxine-pyrimethamine was not widely available at the
participating ANCs as it was not officially endorsed by
the government for preventive use during pregnancy.
The current national drug policy guidelines on malaria
do not mention IPTp [31]. Given that the intensity of
transmission is lower in Jharkhand [20] and Chhattis-
garh [21,22] relative to many areas of sub-Saharan
Africa, widespread implementation may unnecessarily
expose pregnant women and their fetuses to the medi-
cations. However, there may be circumstances that war-
rant IPTp use, for example more intense transmission in
remote tribal villages or during episodic outbreaks.
Participating HCWs and pregnant women were cogni-
zant that study personnel were affiliated with a malaria
research study which may have biased our results by
overinflating the emphasis on malaria during ANC
visits. Nevertheless, this study suggests that a disconnect
remains between routine antenatal practices in India
and known strategies to prevent and treat malaria in
pregnancy. The use of ITNs in particular, which may be
useful even in settings of unstable transmission, appears
underutilized. Maintaining a sufficient supply of malaria
diagnostic materials and antimalarials safe for use in
pregnancy is crucial to effective case recognition and
management. Gaps highlighted by this study combined
with recent estimates of the prevalence of malaria in
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Page 7 of 9pregnancy specific to India should be used to revise gov-
ernmental policy and target increased educational efforts
among health care workers and pregnant women.
Conclusion
This study identified a major disconnect between rou-
tine antenatal practices in India and known strategies to
prevent and treat malaria in pregnancy. These gaps,
combined with recent estimates of the prevalence of
malaria in pregnant women in India, should be used to
revise governmental policy and target increased educa-
tional efforts among health workers and pregnant
women. Specifically, we recommend that HCWs routi-
nely query pregnant women at each ANC visit about
the presence of a fever and obtain a targeted blood
smear for women with this history. In addition, there
should be an increased focus at ANC visits upon distri-
bution of insecticide-treated bednets along with
improved education surrounding the benefits of utiliza-
tion during pregnancy. Finally, national drug policy
guidelines for the treatment of malaria should include
specific recommendations for safe antimalarials for
treatment during pregnancy and specify those situations,
such as episodic outbreaks, where preventive therapy
may be warranted.
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